Y-mAbs

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Y-mAbs and other ETFs, options, and stocks.

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.

CEO

Michael Rossi

CEOMichael Rossi

Employees

107

Employees107

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2015

Founded2015

Employees

107

Employees107

YMAB Key Statistics

Market cap

176.58M

Market cap176.58M

Price-Earnings ratio

-5.81

Price-Earnings ratio-5.81

Dividend yield

—

Dividend yield—

Average volume

214.08K

Average volume214.08K

High today

$4.26

High today$4.26

Low today

$3.87

Low today$3.87

Open price

$4.06

Open price$4.06

Volume

441.22K

Volume441.22K

52 Week high

$16.11

52 Week high$16.11

52 Week low

$3.76

52 Week low$3.76

Analyst ratings

83%

of 12 ratings

Buy

83.3%

Hold

Sell

16.7%

People also own

Based on the portfolios of people who own YMAB. This list is generated using Robinhood data, and it’s not a recommendation.